The Seed Investor News Roundup

Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN

There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

Read the Investors Guide To Newly Emerging Marijuana Markets

Aurora Cannabis Accelerates European Expansion With Licensed Denmark Joint Venture

Planned 1,000,000 Square Foot High-Tech Facility Will Establish "Aurora Nordic Cannabis" as Europe's Largest Cannabis Producer

INMED CLOSES OVER-SUBSCRIBED C$9.4 MILLION FINANCING

InMed Pharmaceuticals, Inc. (CSE:IN; OTCQB: IMLFF), has closed its previously announced non-brokered private placement for gross proceeds of C$9.4 Million through the issuance of 13,428,571 units, with terms as previously announced on December 18, 2017.

Sessions to rescind Obama-era rules on non-interference with states where pot is legal

In a seismic shift, Attorney General Jeff Sessions will announce Thursday that he is rescinding a trio of memos from the Obama administration that adopted a policy of non-interference with marijuana-friendly state laws.

Liberty Health Sciences Inc. Announces Proposed Acquisition of a 387 Acre Parcel of Land in Gainesville Including 200,000 Square Feet of Greenhouse and Processing Facilities

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it has entered into a binding term sheet to acquire all of the issued and outstanding shares of 242 Cannabis Canada Ltd., whose wholly-owned subsidiary 242 Cannabis, LLC, has agreed to purchase a 387 acre parcel of land in Gainesville, Florida.

Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed investment advisor.

TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260

info@theseedinvestor.com

To keep receiving emails from us, please add us to your address book.